| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.24 | 1e-07 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |